Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

USA TODAY created dozens of visual stories and graphics to inform Americans about COVID-19, the evolving science around it and how to cope during the pandemic. We also dug deep into ...

Health agencies, counties and state officials have been resisting efforts to provide booster jabs to Americans this fall.

Image Credit: Billion Photos/Shutterstock.com A recent study in Vaccine analyzed public health data to assess the impact of ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

One specific type of viral exanthem that dermatologists have seen with COVID is a morbilliform rash, meaning a measles-like rash. Measles rashes tend to look like small raised bumps that eventually ...

A jury has awarded more than $12 million to a woman who lost her job at a Michigan insurance company after declining to get a COVID-19 vaccination.

P resident-elect Donald Trump’s victory over Vice President Kamala Harris means U.S. health policy may soon be shaped, at least in part, by one of the country’s most notorious vaccine skeptics: Robert ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory ...

The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same ...